- $178.93m
- $318.15m
- $11.76m
Annual balance sheet for CapsoVision, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS/A | PROSPECTUS/A |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash | ||
| Cash and Short Term Investments | 14.6 | 9.32 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 1.87 | 2 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 19.2 | 14.8 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 2.28 | 1.92 |
| Other Long Term Assets | ||
| Total Assets | 21.5 | 16.8 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 1.51 | 1.8 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 2.75 | 2.69 |
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 18.8 | 14.1 |
| Total Liabilities & Shareholders' Equity | 21.5 | 16.8 |
| Total Common Shares Outstanding |